Search research articles
Contact Us
Filters
Showing results (141-150 of 148) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 148 results.
Science Immunology
|
June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancer
Clara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Scientific Reports
|
December 5, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study
Tobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.
International Journal of Cancer
|
April 23, 2021
Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets
Lara Bußmann, Konstantin Hoffer, Clara Marie von Bargen, et al.
Nature Communications
|
January 29, 2025
Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting
Anaïs Cardon, Thomas Guinebretière, Chuang Dong, et al.
The Lancet. Haematology
|
May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Science Immunology
|
February 24, 2021
Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients
Yu Zhao, Christoph Kilian, Jan-Eric Turner, et al.
The Lancet. Haematology
|
October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Frontiers in Immunology
|
June 14, 2023
Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults
Ricards Marcinkevics, Pamuditha N Silva, Anna-Katharina Hankele, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 148) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 148 results.
Science Immunology
|
June 5, 2026
Cytotoxic CD39<sup>+</sup> tumor-associated NK cells respond to NKG2A blockade in lung cancer
Clara Serger, Lucas Rebuffet, Michael T Sandholzer, et al.
Scientific Reports
|
December 5, 2025
Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study
Tobias Hegelmaier, Alexander Duscha, Christiane Desel, et al.
International Journal of Cancer
|
April 23, 2021
Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets
Lara Bußmann, Konstantin Hoffer, Clara Marie von Bargen, et al.
Nature Communications
|
January 29, 2025
Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting
Anaïs Cardon, Thomas Guinebretière, Chuang Dong, et al.
The Lancet. Haematology
|
May 3, 2016
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Science Immunology
|
February 24, 2021
Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients
Yu Zhao, Christoph Kilian, Jan-Eric Turner, et al.
The Lancet. Haematology
|
October 22, 2017
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial
Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski, et al.
Frontiers in Immunology
|
June 14, 2023
Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults
Ricards Marcinkevics, Pamuditha N Silva, Anna-Katharina Hankele, et al.
Page
of 15